FindTrial
Sign In

Thipilliver Chooranam for Ringworm Fungal Infection

Treatment of Tinea Corporis (Padarthamarai) with Thipilliver Chooranam A Pilot Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086449
Enrollment
20
Registered
2025-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

Intervention1: Thipilliver Chooranam: Thipilliver Chooranam is a powder form of siddha medicine. It will be taken from 500 mg to 1 g with honey, Thrice a day, after food for a period of 1 month Contro

Sponsors

The Central Council for Research in Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who have ringworm infection

Exclusion criteria

Exclusion criteria: 1. Immunocompromised patients 2. Children, Adolescent Pregnant/ Lactating women 3. Patients who have history of hypersensitivity/ Allergy 4. Patients associated with other skin conditions

Design outcomes

Primary

MeasureTime frame
The primary outcome will be based on the resolution of skin lesions.Timepoint: The outcome will be assessed after 4 weeks of intervention—

Secondary

MeasureTime frame
The secondary outcome will be based on the absence of fungi on the skin in the KOH wet mount test.Timepoint: The outcome will be taken after 4 weeks of treatment.—

Countries

India

Contacts

Public ContactChitra. U

Government Siddha Medical College

mmsankar2000@gmail.com9445716802

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026